LVJI TECH (01745.HK): Further Delays Circular for Very Substantial Disposal of Debt Claims to 16 October
NewTimeSpace News: On 25 September 2026, Lvji Technology Holdings Inc. (stock code: 01745) announced a further delay in the despatch of the circular relating to the very substantial disposal of debt claims: the circular was originally expected to be despatched on or before 25 September 2026, and the expected date of despatch is now delayed to on or before 16 October 2026, as the Company needs more time to prepare and finalise the relevant information for inclusion in the circular.
Reference is made to the Company's announcements dated 5 August 2026 regarding the very substantial disposal of debt claims and 2 September 2026 regarding the delayed despatch; this is the second postponement of the circular. The circular will contain, among other things, further details of the disposal, other information required to be disclosed under the Listing Rules, and the notice of the extraordinary general meeting.
The announcement was signed by Chairman and executive Director Zang Weizhong in Guangzhou, China; as at the date of the announcement, the board comprises three executive directors (Zang Weizhong, Wang Lei and Bu Jiale) and four independent non-executive directors (Gu Jianlu, Gu Ruizhen, Wu Qiang and Wang Lu).
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- EDDING GENOR (06998.HK): GB268 Wins NMPA Nod for NSCLC, BTC Trials
- HENLIUS (02696.HK): NMPA Clears HLX105 Phase 1 Solid Tumour IND
- KLIGHT LASER: Closes New Round Led by China Fortune-Tech Capital, Expanding Deep-Ultraviolet Output
- OSMUNDA: Closes RMB 100 Million Series D Led Exclusively by Lishui Green Valley Talent Osmunda New Fund
- INNOVENT BIO (01801.HK): Sintilimab Gets First CHMP Positive Opinion for First-Line NSCLC